KHARRI GUTHRIE: Open Payments
NPI 1194192807 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,112 in 63 payments from 21 companies in 2025. Trend: 2023 $673 · 2024 $996 · 2025 $1,112
Food & beverage: $1,112
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $221 |
| ABBVIE INC. | 11 | $165 |
| PFIZER INC. | 9 | $141 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Dexcom, Inc. | 2 | $49 |
| Verona Pharma, Inc. | 2 | $46 |
| Insulet Corporation | 2 | $39 |
Products named: Wegovy, NURTEC ODT, QULIPTA, Ozempic, MOUNJARO, XIFAXAN, Auvelity, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
